You just read:

Eiger Announces Breakthrough Therapy Designation Granted by FDA for Lonafarnib for Treatment of Hepatitis Delta Virus (HDV) Infection

News provided by

Eiger BioPharmaceuticals, Inc.

Dec 17, 2018, 08:00 ET